Regentis Biomaterials Ltd. (RGNT)
NYSE · Healthcare
Regentis Biomaterials Ltd. EBITDA 2023–2025
Regentis Biomaterials Ltd. annual/quarterly ebitda history and growth rate from 2023 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Regentis Biomaterials Ltd. annual ebitda for 2025 was -13.6 M, a 407.16% decrease from 2024.
- Regentis Biomaterials Ltd. annual ebitda for 2024 was 4.4 M, a 211.64% decrease from 2023.
- Regentis Biomaterials Ltd. annual ebitda for 2023 was -4.0 M.
No data available.
Regentis Biomaterials Ltd. EBITDA — FAQ
Regentis Biomaterials Ltd. (RGNT) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RGNT's ebitda history?
The chart and table above show Regentis Biomaterials Ltd.'s ebitda by year and by quarter, including the growth rate.